Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Aimmune Therapeutics, Inc. | d932346ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Aimmune Therapeutics,
Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
August 5, 2015